Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

8.74
Delayed Data
As of Jul 31
 +0.01 / +0.11%
Today’s Change
8.42
Today|||52-Week Range
18.25
-48.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$428.6M

Company Description

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. Its programs focus on the inhibition of phosphoinositide-3-kinase, heat shock protein and fatty acid amide hydrolase. Infinity Pharmaceuticals was founded on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
780 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336

Employees

Shareholders

Mutual fund holders60.11%
Other institutional47.08%
Individual stakeholders20.11%

Top Executives

Adelene Q. PerkinsChairman, President & Chief Executive Officer
Lawrence E. BlochCFO, Secretary, Treasurer & CAO
John J. KeiltyVP-Information Technology & Informatics
Vito J. PalombellaChief Scientific Officer & Executive VP
Julian AdamsPresident-Research & Development